Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C

被引:14
|
作者
Azim, James [1 ,2 ]
McCurdy, Heather [1 ,2 ]
Moseley, Richard H. [1 ,2 ]
机构
[1] Dept Vet Affairs Med Ctr, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI USA
关键词
Porphyria; Hepatitis C virus; Ribavirin; Pegylated interferon; Hemochromatosis;
D O I
10.3748/wjg.14.5913
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There is a strong association between porphyria cutanea tarda (PCT) and chronic viral hepatitis C. Therapy for chronic viral hepatitis C may improve PCT. However, there are only a few reports of the de novo development of PCT during therapy for chronic viral hepatitis C. We describe the development of PCT in a 56-year-old patient with chronic viral hepatitis C after 12 wk of peginterferon/ribavirin therapy. In addition, the patient was homozygous for the H63D hereditary hemochromatosis gene (HFE) mutation. The association of PCT with chronic viral hepatitis C and the possible role of hepatic iron overload and ribavirin-induced hemolytic anemia in the development of PCT during therapy for chronic viral hepatitis C are discussed. (C) 2008 The WIG Press. All rights reserved.
引用
收藏
页码:5913 / 5915
页数:3
相关论文
共 50 条
  • [1] Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C
    James Azim
    Heather McCurdy
    Richard H Moseley
    World Journal of Gastroenterology, 2008, (38) : 5913 - 5915
  • [2] Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C
    Jessner, W
    Der-Petrossian, M
    Christiansen, L
    Maier, H
    Steindl-Munda, P
    Gangl, A
    Ferenci, P
    HEPATOLOGY, 2002, 36 (05) : 1301 - 1302
  • [3] Hepatitis C and porphyria cutanea tarda
    English, JC
    Peake, MF
    Becker, LE
    CUTIS, 1996, 57 (06): : 404 - 408
  • [4] Porphyria Cutanea Tarda Associated with Hepatitis C
    Sacks, Chana A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : E86 - E86
  • [5] Hepatitis C, hemochromatosis and porphyria cutanea tarda
    Teubner, A
    Richter, M
    Schuppan, D
    Köstler, E
    Stölzel, U
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (13) : 691 - 695
  • [6] ASSOCIATION OF CHRONIC HEPATITIS-C AND PORPHYRIA-CUTANEA-TARDA
    WILLSON, RA
    KIRBY, P
    HART, J
    HEPATOLOGY, 1992, 16 (04) : A225 - A225
  • [7] PORPHYRIA-CUTANEA-TARDA AND CHRONIC HEPATITIS-C - OUTCOME AFTER INTERFERON THERAPY
    GRASSET, D
    NOUGUE, J
    SEIGNEURIC, C
    LANDREAUD, M
    VOIGT, JJ
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1994, 18 (12): : 1148 - 1149
  • [8] Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C
    Fernández, I
    Castellano, G
    de Salamanca, RE
    Colina, F
    de la Cámara, A
    Morán, MJ
    Muñoz, R
    Solís-Herruzo, JA
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (03) : 314 - 319
  • [9] Occurrence of porphyria cutanea tarda during peginterferon/ribavirin therapy for chronic viral hepatitis C
    Thevenot, T
    Bachmeyer, C
    Harami, R
    Dumouchel, P
    Ducamp-Posak, I
    Cadranel, JF
    JOURNAL OF HEPATOLOGY, 2005, 42 (04) : 607 - 608
  • [10] Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda
    Singal, Ashwani K.
    Venkata, Krishna V. R.
    Jampana, Sarat
    Fakhar-Ul Islam
    Anderson, Karl E.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (06): : 523 - 528